BriefCase-Triage vs Tempus ECG-AF
AI Verdict
Choose BriefCase-Triage if…
Choose BriefCase-Triage if your health system requires a comprehensive AI solution to optimize radiology workflows by rapidly identifying and prioritizing critical findings across a wide range of medical imaging studies. This tool is ideal for improving efficiency and patient outcomes in emergency medicine, neurology, and other specialties where timely detection of acute conditions is paramount, offering real-time alerts and mobile care coordination.
View BriefCase-Triage →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your cardiology or internal medicine department aims to proactively identify elderly patients at increased risk of developing new-onset atrial fibrillation within the next year. This specialized AI algorithm is best suited for analyzing 12-lead ECGs from patients aged 65 or older without a prior AF diagnosis, enabling earlier intervention and follow-up care.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | BriefCase-Triage | Tempus ECG-AF |
|---|---|---|
| Pricing | Enterprise pricing starts at approximately $50,000 per site per year. | Contact vendor |
| Deployment | Cloud-based. Aidoc's platform runs on AWS and Azure. The deployment process is described as lightweight, straightforward, and can be up and running in 2 to 3 weeks with minimal effort from facility IT. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
| EHR Integration | Epic | Not specified |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
BriefCase-TriageBriefCase-Triage offers seamless integration with existing hospital systems like PACS and EHR, and crucially, provides a mobile app for care coordination. This mobile accessibility and broad integration enhance workflow flexibility and overall user experience for clinicians on the go.
Clinical Value
BriefCase-TriageWhile both tools are FDA-cleared and provide significant clinical value, BriefCase-Triage offers a comprehensive triage solution for multiple indications in one workflow, demonstrating an 'order-of-magnitude reduction in false alerts' and improved diagnostic accuracy in pivotal studies. This broad impact on radiology workflow efficiency and patient safety across various acute conditions gives it an edge.
Pricing & Value
Tempus ECG-AFTempus ECG-AF stands out with explicit CMS reimbursement availability, including specific CPT codes and a Medicare rate, effective January 1, 2025. This clear financial pathway for adoption and utilization provides a more tangible and immediate value proposition for healthcare providers compared to BriefCase-Triage's enterprise pricing requiring vendor contact.
Enterprise Readiness
BriefCase-TriageAidoc's BriefCase-Triage demonstrates superior enterprise readiness, explicitly mentioning SOC2, GDPR compliance, API availability, cloud deployment, ISO 13485:2016 certification, and a substantial global customer base of over 1,600 hospitals. This comprehensive suite of certifications and widespread adoption indicates a more mature and robust offering for large-scale healthcare environments.
Innovation
BriefCase-TriageBriefCase-Triage, built on Aidoc's self-developed AI foundation model (CAREu2122) and featuring a continuous learning model, represents a more expansive and adaptable approach to AI innovation. Its aim for end-to-end clinical AI workflows and comprehensive triage across multiple indications suggests a broader platform-level innovation.
Support & Docs
BriefCase-TriageAidoc offers a comprehensive 'customer success team' that provides proactive training, educational content, performance tracking, and programs like 'AI PATH' for adoption and workflow enhancement. This integrated approach to ongoing support and value realization is more robust than Tempus's standard contact channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase-Triage | Tempus ECG-AF |
|---|---|---|
| Product Name | BriefCase-Triage | Tempus ECG-AF |
| Primary Function | FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Company | Aidoc Medical | Tempus AI, Inc. |
| Target Specialties | Cardiology, Emergency Medicine, General Surgery, Neurology, Oncology, Radiology | Cardiology, Geriatrics, Internal Medicine |
| Key Functionality Focus | AI-powered analysis of medical imaging, real-time alerts and notifications, prioritization of critical cases, comprehensive triage solution (multiple indications). | AI-based algorithm for 12-lead ECG analysis, detects signs associated with new onset Atrial Fibrillation (AF) within 12 months, trained on over 1.5 million ECGs. |
| Target User/Patient Group | Physicians; Solo to large health systems. | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
Videos
Demos, reviews, and walkthroughs featuring BriefCase-Triage and Tempus ECG-AF.
Frequently Asked Questions
More Comparisons
More matchups featuring BriefCase-Triage or Tempus ECG-AF
Backers
Who funded each tool's parent company.